SCHEMBL3385769

SCHEMBL3385769

CCCCCCCC(S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+]

nearest known ligand 0.50

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.50
CA1 known ✓ P00915 2/20 0.42
FDPS known ✓ P14324 3/20 0.39
RECQL P46063 2/20 0.47
GLA P06280 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
EPHX2 P34913 1/20 0.47
BLM P54132 1/20 0.47
NR1I2 O75469 1/20 0.46
TP53 P04637 1/20 0.42
GPR84 Q9NQS5 4/20 0.41
FFAR1 O14842 1/20 0.39
NFKB1 P19838 1/20 0.38
FAAH O00519 2/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3386052 1.00 CA2 (0.50) CA2RECQLGLAHPGDTSHR
SCHEMBL3381883 0.98 CA2 (0.47) CA2RECQLGLAHPGDTSHR
Potassium Ion SCHEMBL9280601 0.95 CA2 (0.45) CA2RECQLGLAHPGDTSHR
Potassium Ion SCHEMBL10537891 0.95 CA2 (0.45) CA2RECQLGLAHPGDTSHR
SCHEMBL17219439 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR
SCHEMBL8688848 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR
SCHEMBL9660940 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR
SCHEMBL9756753 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR
SCHEMBL28621358 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR
SCHEMBL17336061 0.86 RECQL (0.47) CA2RECQLGLAHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8900641-B2 Antimicrobial composition NALCO COMPANY (US) 2014-12-02 US disclosed
EP-2097355-B1 ANTIMICROBIAL COMPOSITION NALCO CO (US) 2012-07-04 EP disclosed
EP-1383462-B1 COSMETIC COMPOSITIONS CONTAINING DISPERSION POLYMERS ONDEO NALCO CO (US) 2010-12-01 EP disclosed
WO-2010093847-A1 ANTIMICROBIAL COMPOSITION NALCO COMPANY (US) 2010-08-19 WO disclosed
EP-2097355-A1 ANTIMICROBIAL COMPOSITION Nalco Company (US) 2009-09-09 EP disclosed
US-20090214672-A1 ANTIMICROBIAL COMPOSITION ECOLAB USA INC. 2009-08-27 US disclosed
WO-2008083263-A1 ANTIMICROBIAL COMPOSITION NALCO COMPANY (US) 2008-07-10 WO disclosed
US-20080160104-A1 ANTIMICROBIAL COMPOSITION NALCO COMPANY 2008-07-03 US disclosed
EP-1490581-A4 USE OF DISPERSION POLYMERS AS FRICTION REDUCERS IN AQUEOUS FRACTURING FLUIDS NALCO ENERGY SERVICES LP (US) 2006-09-13 EP disclosed
EP-1490581-A1 USE OF DISPERSION POLYMERS AS FRICTION REDUCERS IN AQUEOUS FRACTURING FLUIDS Nalco Energy Services, L.P. (US) 2004-12-29 EP disclosed
US-20030059382-A1 Cosmetic compositions containing dispersion polymers ECOLAB USA INC. 2003-03-27 US disclosed
WO-2002083085-A1 COSMETIC COMPOSITIONS CONTAINING DISPERSION POLYMERS ONDEO NALCO COMPANY (US) 2002-10-24 WO disclosed
EP-0929582-B1 CATIONIC WATER-SOLUBLE POLYMER PRECIPITATION IN SALT SOLUTIONS CYTEC TECH CORP (US) 2001-11-14 EP disclosed
US-6013708-A PRECIPITATING IN WATER SOLUTION COMPRISING AT LEAST ONE KOSMOTROPIC SALT, AND AT LEAST ONE ANIONIC ORGANIC SALT CYTEC TECHNOLOGY CORP. (US) 2000-01-11 US disclosed
US-5934839-A CATIONIC POLYMER, ANIONIC ORGANIC SALT, KOSMOTROPIC SALT; SOIL CONDITIONERS CYTECTECHNOLOGY CORP. (US) 1999-08-10 US disclosed
EP-0929582-A1 CATIONIC WATER-SOLUBLE POLYMER PRECIPITATION IN SALT SOLUTIONS Cytec Technology Corp. (US) 1999-07-21 EP disclosed
US-5885032-A ADDING TO THE SOIL A SOIL CONDITIONING AMOUNT OF AQUEOUS SOLUTION CONTAINING A CHAOTROPIC SALT, A KESMOTROPIC SALT AND A PRECIPITATED CATIONIC WATER SOLUBLE POLYMER CYTEC TECHNOLOGY CORP. (US) 1999-03-23 US disclosed
US-5738794-A Cationic water-soluble polymer preciptation in salt solutions CYTEC TECHNOLOGY CORP. (US) 1998-04-14 US disclosed
WO-1998014490-A1 CATIONIC WATER-SOLUBLE POLYMER PRECIPITATION IN SALT SOLUTIONS CYTEC TECHNOLOGY CORP. (US) 1998-04-09 WO disclosed
US-5733462-A FLOCCULATION, SOIL CONDITIONING, WASTE TREATMENT CYTEC TECHNOLOGY CORP. (US) 1998-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030059382-A1 Cosmetic compositions containing dispersion polymers POLR1C, NACA, TYR CA2 3210/4885CA1 4395/4885FDPS 4028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.